Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Saioa Mendaza"'
Autor:
Ibone Labiano, Ana E. Huerta, Maria Alsina, Hugo Arasanz, Natalia Castro, Saioa Mendaza, Arturo Lecumberri, Iranzu Gonzalez-Borja, David Guerrero-Setas, Ana Patiño-Garcia, Gorka Alkorta-Aranburu, Irene Hernández-Garcia, Virginia Arrazubi, Elena Mata, David Gomez, Antonio Viudez, Ruth Vera
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Pancreatic ductal adenocarcinoma represents one of the solid tumors showing the worst prognosis worldwide, with a high recurrence rate after adjuvant or neoadjuvant therapy. Circulating tumor DNA analysis raised as a promising non-invasive t
Externí odkaz:
https://doaj.org/article/f92620ce655e4f569495af68107a7fe1
Autor:
Saioa Mendaza, David Guerrero-Setas, Iñaki Monreal-Santesteban, Ane Ulazia-Garmendia, Alicia Cordoba Iturriagagoitia, Susana De la Cruz, Esperanza Martín-Sánchez
Publikováno v:
Biomedicines, Vol 9, Iss 10, p 1394 (2021)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlabo
Externí odkaz:
https://doaj.org/article/0b8dc928960b41349bf05e3df61ac812
Autor:
Saioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, Imanol Arozarena, David Guerrero-Setas, Tamara Zudaire, Rosa Guarch, August Vidal, José-Santos Salas, Xavier Matias-Guiu, Karina Ausín, Carmen Gil, Rubén Hernández-Alcoceba, Esperanza Martín-Sánchez
Publikováno v:
Cancers, Vol 13, Iss 7, p 1739 (2021)
No therapeutic targets and molecular biomarkers are available in cervical cancer (CC) management. In other cancer types, micro-RNA-877-3p (miR-877-3p) has been associated with events relevant for CC development. Thus, we aimed to determine miR-877-3p
Externí odkaz:
https://doaj.org/article/3e18bdafd741478d90d4d1eeb00ac3b9
Autor:
Saioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, Tamara Zudaire, Rosa Guarch, David Guerrero-Setas, August Vidal, José Santos-Salas, Xavier Matias-Guiu, Karina Ausín, María José Díaz de Cerio, Esperanza Martín-Sánchez
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6, p 2125 (2020)
The tumor-suppressor protein p16 is paradoxically overexpressed in cervical cancer (CC). Despite its potential as a biomarker, its clinical value and the reasons for its failure in tumor suppression remain unclear. Our purpose was to determine p16 cl
Externí odkaz:
https://doaj.org/article/a2941376fdc946dba47a33b9b53e4a76
Autor:
Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal-Santesteban, Alicia Córdoba, Yerani Ruiz de Azúa, Begoña Aguiar, Raquel Beloqui, Pedro Armendáriz, Marta Arriola, Esperanza Martín-Sánchez, David Guerrero-Setas
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 3, p 903 (2020)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can be useful for identifying pot
Externí odkaz:
https://doaj.org/article/e3ee65772e694c019134299a047040ae
Autor:
Alicia Cordoba Iturriagagoitia, Esperanza Martín-Sánchez, Iñaki Monreal-Santesteban, Ane Ulazia-Garmendia, David Guerrero-Setas, Susana De La Cruz, Saioa Mendaza
Publikováno v:
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Biomedicines
Volume 9
Issue 10
Biomedicines, Vol 9, Iss 1394, p 1394 (2021)
instname
Biomedicines
Volume 9
Issue 10
Biomedicines, Vol 9, Iss 1394, p 1394 (2021)
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlabo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58b9b18efb5c78590383cd6a5156830
https://hdl.handle.net/2454/42653
https://hdl.handle.net/2454/42653
Autor:
Karina Ausín, David Guerrero-Setas, Saioa Mendaza, José Santos-Salas, Joaquín Fernández-Irigoyen, Xavier Matias-Guiu, Enrique Santamaría, August Vidal, María José Díaz de Cerio, Rosa Guarch, Tamara Zudaire, Esperanza Martín-Sánchez
Publikováno v:
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
International Journal of Molecular Sciences, Vol 21, Iss 6, p 2125 (2020)
Repositorio Abierto de la UdL
Universitad de Lleida
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
International Journal of Molecular Sciences
Volume 21
Issue 6
instname
International Journal of Molecular Sciences, Vol 21, Iss 6, p 2125 (2020)
Repositorio Abierto de la UdL
Universitad de Lleida
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
International Journal of Molecular Sciences
Volume 21
Issue 6
The tumor-suppressor protein p16 is paradoxically overexpressed in cervical cancer (CC). Despite its potential as a biomarker, its clinical value and the reasons for its failure in tumor suppression remain unclear. Our purpose was to determine p16 cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c1d9294ec6a5d08f0561bdd35ca329
https://hdl.handle.net/2454/37755
https://hdl.handle.net/2454/37755
Autor:
Begoña Aguiar, Raquel Beloqui, Yerani Ruiz de Azúa, Iñaki Monreal-Santesteban, Marta Arriola, Alicia Córdoba, David Guerrero-Setas, Ane Ulazia-Garmendia, Pedro Armendáriz, Esperanza Martín-Sánchez, Saioa Mendaza
Publikováno v:
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
International Journal of Molecular Sciences, Vol 21, Iss 3, p 903 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 3
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Universidad Pública de Navarra
International Journal of Molecular Sciences, Vol 21, Iss 3, p 903 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 3
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can be useful for identifying pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668f749a61183d0a57ca32d99c25d130
https://hdl.handle.net/2454/37754
https://hdl.handle.net/2454/37754
Autor:
Francisco Vicente-Garcia, Ane Ulazia-Garmendia, Esperanza Martín-Sánchez, David Guerrero-Setas, Alicia Córdoba, Iñaki Monreal-Santesteban, Idoia Blanco-Luquin, Susana De La Cruz, Ana Aramendia, Saioa Mendaza
Publikováno v:
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Clinical Epigenetics
Universidad Pública de Navarra
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Clinical Epigenetics
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in colorectal cancer, whereas it is dow
Autor:
David Guerrero-Setas, Noemi Perez-Janices, Iñaki Monreal-Santesteban, Francisco Vicente-Garcia, Idoia Blanco-Luquin, Manel Esteller, Diego Megías, Esperanza Martín-Sánchez, Ane Ulazia-Garmendia, Paula Lopez-Serra, David Escors, Jose Juan Illarramendi, Alicia Córdoba, Saioa Mendaza
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Repisalud
Instituto de Salud Carlos III (ISCIII)
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Oncotarget
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Repisalud
Instituto de Salud Carlos III (ISCIII)
Academica-e: Repositorio Institucional de la Universidad Pública de Navarra
Universidad Pública de Navarra
Oncotarget
The CHL1 gene encodes a cell-adhesion molecule proposed as being a putative tumour-suppressor gene in breast cancer (BC). However, neither the underlying molecular mechanisms nor the clinical value of CHL1 downregulation in BC has been explored. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9085ebe7251266669318ba13c1a23b0b
https://hdl.handle.net/2454/32047
https://hdl.handle.net/2454/32047